Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 12, 2010, Pages 1408-1409

  Green, Alison J E ^a   Andrews, M M ^a   Bishop, M T ^a   McKenzie, J M ^a   McCord, Y ^a   Pennington, C ^a   Chohan, G ^a   Knight, R S G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN 14 3 3; PROTEIN S100B; PROTEIN TAU PT 181; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CODON; CREUTZFELDT JAKOB DISEASE; GENETIC VARIABILITY; HUMAN; LETTER; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VISUAL HALLUCINATION;

EID: 78649581050     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.183418     Document Type: Letter

References (6)

1. Kashi D, Mead S, Hyare H, et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009;374:2128.
2. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt - Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 2003;24:1560-9.
3. http://www.cjd.ed.ac.uk/criteria.htm#vCJD.
4. Green AJE, Thompson EJ, Stewart GE, et al. The use of CSF 14-3-3 and other brain-specific proteins in the diagnosis of variant Creutzfeldt - Jakob disease. J Neurol Neurosurg Psych 2001;70:744-8.
5. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt - Jakob disease. Neurology 2006;67:637-43.
6. Goodall CA, Head MW, Everington D, et al. Raised CSF phospho-tau concentrations in variant CJD: diagnostic and pathological implications. J Neurol Neurosurg Psych 2006;77:89-91.